Dominant epitopes and synthetic peptides in myasthenia gravis.
Sela
M
M
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Kirshner
S L
SL
Katz-Levy
Y
Y
Zisman
E
E
Mozes
E
E
D000818:Animals; D006801:Humans; D016056:Immunodominant Epitopes / Q000276:immunology* / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000276:immunology*; D010455:Peptides / Q000276:immunology / Q000627:therapeutic use*
D016056:Immunodominant Epitopes; D010455:Peptides; C021759:(T,G)-A-L